Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TFAP2E antisense RNA 1 (TFAP2E-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 1 (hg38: chr1:35569807-35577808) that is transcribed antisense to the TFAP2E gene[3][7]. TFAP2E-AS1 does **not** encode a protein but is involved in the *regulation of gene expression*, particularly by influencing neighboring or distant genes at the RNA level. Experimental evidence suggests that TFAP2E-AS1 may act as a suppressor of cell proliferation and migration in gastric cancer, an effect positively mediated by the transcription factor KLF15 via downstream modulation of miR-3657[8]. Additionally, TFAP2E-AS1 is implicated in the regulation of immune cell (monocyte) activity, suggesting a possible role in the pathogenesis or modification of chronic inflammation and certain cancers[10]. There are no known small-molecule drugs or biologicals that directly interact with TFAP2E-AS1, and it is not considered a classic therapeutic target such as a receptor, enzyme, transporter, or transcription factor. However, its altered expression has been noted as a potential biomarker for cancer prognosis and possibly for immune-related diseases[8][10].
Not applicable (no directly interacting drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TFAP2E antisense RNA 1 (TFAP2E-AS1).